Michael R Hayden Xenon Pharmaceuticals Inc. (XENE) insider trading activity
Michael R Hayden is Director of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 116,206 shares of XENE, which is worth approximately $4.49 Million. The most recent transaction as insider was on May 18, 2021, when has been sold 3,500 shares (Common Shares) at a price of $3.85 per share, resulting in proceeds of $13,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
116K
0%
3M change
0%
12M change
Total Value Held
$4.49 Million
Michael R Hayden Transaction History
Also insider at
MRH
Michael R Hayden
Director
Carlsbad, CA